You are here: All Products  > Hasten Biopharma Enters $325 Million Deal for PCSK9 Cholesterol Drug

Hasten Biopharma Enters $325 Million Deal for PCSK9 Cholesterol Drug

Price: $5.00
Available

Get instant access to this article for unlimited viewing and/or downloading for seven days.


Back to products